We audited early Meta campaign performance and identified inefficient targeting, weak creative differentiation, and unclear messaging for a 45+ longevity-focused audience. We also reviewed how the product was being positioned and found that early campaigns were not clearly communicating the value of Hydroxytyrosol or its long-term health benefits, which was limiting conversion efficiency.

We launched broad testing campaigns across Meta to rapidly identify high-performing creative angles, messaging themes, and audience segments. The focus was on uncovering which narratives resonated most strongly, Including cardiovascular health support, inflammation reduction, and healthy aging - while allowing the algorithm to surface high-intent buyers within the 45+ demographic.

We analyzed early purchase data and systematically shifted budget toward top-performing creatives and audience segments. Underperforming ads were removed, while winning combinations were scaled. This optimization phase directly improved efficiency, reducing cost per result from $162.74 to $104.93 while increasing total purchase volume.

We expanded spend across proven segments and refined messaging to better align with long-term wellness and longevity motivations. Continuous creative testing and funnel refinement helped increase purchase volume while maintaining improved acquisition efficiency and establishing a scalable, data-driven growth system.